Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 3Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1

Conditions

Vomiting 5Neoplasms 3Nausea 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Sarcoma 1Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy 1Ovarian Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Multiple Myeloma 1Genital Neoplasms, Female 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1

Interventions

Dexamethasone 22Ondansetron 20Aprepitant 20Palonosetron 17Granisetron 11Calcium Dobesilate 8Therapeutics 7Olanzapine 6dexamethasone acetate 5Doxorubicin 5Cyclophosphamide 5casopitant 4Acupressure 4netupitant 3dolasetron 3Yoga 3Vincristine 3Radiotherapy 3Dronabinol 3Analgesia 3ginger extract 2fosaprepitant 2dexamethasone 21-phosphate 2Tropisetron 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Prochlorperazine 2Metoclopramide 2Mesna 2Ifosfamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Nausea × fosaprepitant × Clear all
NCT01490060 2016-04-11

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

M.D. Anderson Cancer Center

Phase NA Completed
47 enrolled 6 charts
Sarcoma

Nausea, Neoplasms, Sarcoma, Vomiting

NCT01074697 2015-04-24

GAND-emesis

Odense University Hospital

Phase 3 Completed
246 enrolled

Genital Neoplasms, Female, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡